This inventor holds 2 USPTO granted patents. Top assignees: Grunenthal Gmbh, Other. Active years: 1978-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1978-1980
Title: Innovations of Hubert Maria Van Wersch
Introduction
Hubert Maria Van Wersch is a notable inventor based in Kerkrade, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds effective against gram-negative bacteria. His work has led to the filing of multiple patents, showcasing his innovative approach to drug composition.
Latest Patents
Van Wersch holds 2 patents related to diazaborines and drug compositions. His latest patents focus on derivatives of 1-hydroxy-benzo-2,3,1-diazaborines, which are substituted in the 2-position by a sulfo group linked to a defined aliphatic radical, such as alkyl or alkenyl. These compounds may also be substituted on the benzene ring by one or more lower alkyl radicals and/or halogen atoms. The pharmaceutical compositions containing these diazaborines have shown high effectiveness against gram-negative bacteria. The new compounds are synthesized by reacting o-formyl phenyl boric acid with the respective aliphatic sulfonic acid hydrazide.
Career Highlights
Throughout his career, Van Wersch has worked with various companies, including Grunenthal GmbH. His innovative contributions have been recognized in the pharmaceutical industry, particularly in the development of effective antibacterial agents.
Collaborations
Some of his notable coworkers include Siegfried Herrling and Heinrich Muckter. Their collaborative efforts have contributed to the advancement of research in the field of pharmaceuticals.
Conclusion
Hubert Maria Van Wersch is a distinguished inventor whose work in diazaborines and drug compositions has made a significant impact in the fight against bacterial infections. His innovative spirit and dedication to research continue to inspire advancements in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile